sai ryusyu

FacultyDepartmentofInfectionandImmunityDivisionofBacteriology
Job titleProfessorWeb site

Profile

Research Keywords

    Bacteriology, Infectious Diseases, Virology

Research Areas

  • Basic medicine / Bacteriology (including mycology)
  • Basic medicine / Virology
  • Clinical internal medicine / General internal medicine (including psychosomatic medicine)

Career

  • Jul.1985
    -
    Jun.1994
    The Fourth Millitary Medical University University affiliated 1th hospital, Physician, Lecturer
  • Jul.1995
    -
    Jun.1997
    WHO Collaborating Center for Virus Reference and Research on HFRS (Hantavirus), Seoul, Korea. Postdoc
  • Jul.1997
    -
    Mar.1998
    Juntendo Univ. Visiting researcher
  • Apr.1998
    -
    Mar.2002
    Juntendo Univ. Asistant professor
  • Apr.2002
    -
    Mar.2007
    Juntendo Univ. Lecturer
  • Apr.2007
    -
    Jan.2012
    Juntendo Univ. Associate professor
  • Feb.2012
    -
    Mar.2015
    Vice Director, RCAI, Kitasato University Institute
  • Apr.2015
    -
    Today
    Jichi Medical Univ. Prof.
  • http://www.jj.em-net.ne.jp/~longzhu/data/cui_cv.htm

Academic Societies

  • The Japan China Medical Association
  • THE JAPANESE SOCIETY FOR CLINICAL MICROBIOLOGY
  • JAPANESE SOCIETY FOR INFECTION PREVENTION AND CONTROL
  • American Society for Microbiology
Display all
Academic Societiesclose
  • The Japan China Medical Association
  • THE JAPANESE SOCIETY FOR CLINICAL MICROBIOLOGY
  • JAPANESE SOCIETY FOR INFECTION PREVENTION AND CONTROL
  • American Society for Microbiology

Research Activities

Papers(paper)

  • Fatal Fulminant Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus Negative for Major High-Virulence Factors Following Influenza B Virus Infection.
    Masaki K, Ishii M, Anraku M, Namkoong H, Miyakawa R, Nakajima T, Fukunaga K, Naoki K, Tasaka S, Soejima K, Sayama K, Sugita K, Iwata S, Cui L, Hanaki H, Hasegawa N, Betsuyaku T
    The American journal of case reports 16 454-458 Jul. 2015
  • A very rare case of primary meningococcal arthritis in an adult male.
    Nihonyanagi S, Sunakawa K, Cui L, Masaki T, Wada T, Hoshiyama T, Nakamura M, Takayama Y, Kanoh Y, Ogawa A, Shichiri M, Hanaki H
    Clinical case reports 3(2) 76-80 Feb. 2015
  • "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
    Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K
    Antimicrobial agents and chemotherapy 58(9) 5024-5035 Sep. 2014
  • Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.
    Hanaki H, Cui L, Ikeda-Dantsuji Y, Nakae T, Honda J, Yanagihara K, Takesue Y, Matsumoto T, Sunakawa K, Kaku M, Tomono K, Fukuchi K, Kusachi S, Mikamo H, Takata T, Otsuka Y, Nagura O, Fujitani S, Aoki Y, Yamaguchi Y, Tateda K, Kadota J, Kohno S, Niki Y
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20(9) 527-534 Sep. 2014
  • Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M, Cui L, Kim J, Hiramatsu K
    Antimicrobial agents and chemotherapy 57(12) 5843-5853 Dec. 2013
  • Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K
    Antimicrobial agents and chemotherapy 57(10) 4861-4871 Oct. 2013
  • Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures.
    Matsui H, Kimura J, Higashide M, Takeuchi Y, Okue K, Cui L, Nakae T, Sunakawa K, Hanaki H
    Clinical and vaccine immunology : CVI 20(9) 1381-1387 Sep. 2013
  • Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
    Yamakawa J, Aminaka M, Okuzumi K, Kobayashi H, Katayama Y, Kondo S, Nakamura A, Oguri T, Hori S, Cui L, Ito T, Jin J, Kurosawa H, Kaneko K, Hiramatsu K
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 18(3) 406-409 Jun. 2012
  • Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria.
    Cui L, Neoh HM, Iwamoto A, Hiramatsu K
    Proceedings of the National Academy of Sciences of the United States of America 109(25) E1647-56 Jun. 2012
  • Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
    Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K
    Antimicrobial agents and chemotherapy 55(9) 4188-4195 Sep. 2011
Display all
Papers(paper)close
  • Fatal Fulminant Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus Negative for Major High-Virulence Factors Following Influenza B Virus Infection.
    Masaki K, Ishii M, Anraku M, Namkoong H, Miyakawa R, Nakajima T, Fukunaga K, Naoki K, Tasaka S, Soejima K, Sayama K, Sugita K, Iwata S, Cui L, Hanaki H, Hasegawa N, Betsuyaku T
    The American journal of case reports 16 454-458 Jul. 2015
  • A very rare case of primary meningococcal arthritis in an adult male.
    Nihonyanagi S, Sunakawa K, Cui L, Masaki T, Wada T, Hoshiyama T, Nakamura M, Takayama Y, Kanoh Y, Ogawa A, Shichiri M, Hanaki H
    Clinical case reports 3(2) 76-80 Feb. 2015
  • "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
    Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K
    Antimicrobial agents and chemotherapy 58(9) 5024-5035 Sep. 2014
  • Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.
    Hanaki H, Cui L, Ikeda-Dantsuji Y, Nakae T, Honda J, Yanagihara K, Takesue Y, Matsumoto T, Sunakawa K, Kaku M, Tomono K, Fukuchi K, Kusachi S, Mikamo H, Takata T, Otsuka Y, Nagura O, Fujitani S, Aoki Y, Yamaguchi Y, Tateda K, Kadota J, Kohno S, Niki Y
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20(9) 527-534 Sep. 2014
  • Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M, Cui L, Kim J, Hiramatsu K
    Antimicrobial agents and chemotherapy 57(12) 5843-5853 Dec. 2013
  • Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K
    Antimicrobial agents and chemotherapy 57(10) 4861-4871 Oct. 2013
  • Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures.
    Matsui H, Kimura J, Higashide M, Takeuchi Y, Okue K, Cui L, Nakae T, Sunakawa K, Hanaki H
    Clinical and vaccine immunology : CVI 20(9) 1381-1387 Sep. 2013
  • Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
    Yamakawa J, Aminaka M, Okuzumi K, Kobayashi H, Katayama Y, Kondo S, Nakamura A, Oguri T, Hori S, Cui L, Ito T, Jin J, Kurosawa H, Kaneko K, Hiramatsu K
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 18(3) 406-409 Jun. 2012
  • Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria.
    Cui L, Neoh HM, Iwamoto A, Hiramatsu K
    Proceedings of the National Academy of Sciences of the United States of America 109(25) E1647-56 Jun. 2012
  • Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
    Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K
    Antimicrobial agents and chemotherapy 55(9) 4188-4195 Sep. 2011
  • walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K
    Antimicrobial agents and chemotherapy 55(8) 3870-3881 Aug. 2011
  • Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus.
    Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K
    Journal of clinical microbiology 49(7) 2680-2684 Jul. 2011
  • An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K
    Antimicrobial agents and chemotherapy 54(12) 5222-5233 Dec. 2010
  • [Community-associated MRSA: current status and molecular epidemiological perspective].
    Ito T, Kuwahara K, Hisata K, Okuma K, Cui L, Hiramatsu K
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 84(5 Suppl 1) 23-33 Sep. 2010
  • Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
    Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K
    Antimicrobial agents and chemotherapy 53(8) 3190-3196 Aug. 2009
  • Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
    Cui L, Neoh HM, Shoji M, Hiramatsu K
    Antimicrobial agents and chemotherapy 53(3) 1231-1234 Mar. 2009
  • Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL, Neoh HM, Cui L, Hiramatsu K
    Antimicrobial agents and chemotherapy 52(12) 4289-4299 Dec. 2008
  • Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus.
    Watanabe Y, Neoh HM, Cui L, Hiramatsu K
    Antimicrobial agents and chemotherapy 52(11) 4207-4208 Nov. 2008
  • Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children.
    Jamaluddin TZ, Kuwahara-Arai K, Hisata K, Terasawa M, Cui L, Baba T, Sotozono C, Kinoshita S, Ito T, Hiramatsu K
    Journal of clinical microbiology 46(11) 3778-3783 Nov. 2008
  • Development and validation of microarray-based assay for epidemiological study of MRSA.
    Otsuka J, Kondoh Y, Amemiya T, Kitamura A, Ito T, Baba S, Cui L, Hiramatsu K, Tashiro T, Tashiro H
    Molecular and cellular probes 22(1) 1-13 Feb. 2008
  • Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
    Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K
    Antimicrobial agents and chemotherapy 52(1) 45-53 Jan. 2008
  • Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.
    Neoh HM, Hori S, Komatsu M, Oguri T, Takeuchi F, Cui L, Hiramatsu K
    Annals of clinical microbiology and antimicrobials 6 13 Oct. 2007
  • Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system.
    Kuroda H, Kuroda M, Cui L, Hiramatsu K
    FEMS microbiology letters 268(1) 98-105 Mar. 2007
  • Persistent bacteraemia due to methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in a patient with erythrodermic psoriasis.
    Bakri FG, Al-Hommos NA, Shehabi A, Naffa RG, Cui L, Hiramatsu K
    Scandinavian journal of infectious diseases 39(5) 457-460 2007
  • Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
    Cui L, Tominaga E, Neoh HM, Hiramatsu K
    Antimicrobial agents and chemotherapy 50(3) 1079-1082 Mar. 2006
  • Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.
    Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K
    Antimicrobial agents and chemotherapy 50(2) 428-438 Feb. 2006
  • Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species.
    Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K
    Journal of bacteriology 187(21) 7292-7308 Nov. 2005
  • DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K
    Antimicrobial agents and chemotherapy 49(8) 3404-3413 Aug. 2005
  • Dissemination of methicillin-resistant staphylococci among healthy Japanese children.
    Hisata K, Kuwahara-Arai K, Yamanoto M, Ito T, Nakatomi Y, Cui L, Baba T, Terasawa M, Sotozono C, Kinoshita S, Yamashiro Y, Hiramatsu K
    Journal of clinical microbiology 43(7) 3364-3372 Jul. 2005
  • Has vancomycin-resistant Staphylococcus aureus started going it alone?
    Hiramatsu K, Cui L, Kuwahara-Arai K
    Lancet (London, England) 364(9434) 565-566 Aug. 2004
  • [Community-associated methicillin-resistant Staphylococcus aureus: current status and molecular epidemiological perspective].
    Ito T, Kuwahara K, Hisata K, Okuma K, Cui L, Hiramatsu K
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 78(6) 459-469 Jun. 2004
  • Antibacterial activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga, against vancomycin-resistant Staphylococcus aureus.
    Isnansetyo A, Cui L, Hiramatsu K, Kamei Y
    International journal of antimicrobial agents 22(5) 545-547 Nov. 2003
  • Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance.
    Yoshida R, Kuwahara-Arai K, Baba T, Cui L, Richardson JF, Hiramatsu K
    The Journal of antimicrobial chemotherapy 51(2) 247-255 Feb. 2003
  • Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.
    Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K
    Journal of clinical microbiology 41(1) 5-14 Jan. 2003
  • Genome and virulence determinants of high virulence community-acquired MRSA.
    Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K
    Lancet (London, England) 359(9320) 1819-1827 May 2002

Papers(other)

  • Please see above site
Display all
Papers(other)close
  • Please see above site

Book

  • Please see above site
Display all
Bookclose
  • Please see above site

Prize

  • http://www.jj.em-net.ne.jp/~longzhu/data/awards.htm,
Display all
Prizeclose
  • http://www.jj.em-net.ne.jp/~longzhu/data/awards.htm,

Outside Fund Adoption

  • Drug resistance in Staphylococus aureus
  • Bacterial genomics
  • Infectious diseases
Display all
Outside Fund Adoptionclose
  • Drug resistance in Staphylococus aureus
  • Bacterial genomics
  • Infectious diseases


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.